The University of Melbourne Centre for Cancer Research is seeking to improve patient outcomes through improved molecular detection and diagnosis of cancer, improved therapeutic clinical decision-making for patients through computational oncology, and the enabling of innovative programs in personalised cancer care.
Watch our weekly seminars on-demand, highlighting the broad range of cancer research undertaken by our groups, and invited guest speakers from across the sector.
Cancer Bioinformatics | Professor Lachlan Coin
Interrogating genome and transcriptome data to identify biomarkers and create new diagnostic tools.
Cancer Epigenetics Lab | Professor Mark Dawson
Understanding the role of epigenetic regulators to identify and trial novel cancer therapies.
Cancer Health Services Research | Professor Maarten IJzerman
Analysing real-world costs and results of comprehensive cancer care to inform evidence-based health service interventions and improve outcomes for cancer patients.
Cancer in Primary Care | Professor Jon Emery
Exploring the role of primary care across the cancer continuum, including studies on cancer screening, cancer diagnosis and survivorship care.
Colorectal Oncogenomics Group | A/Prof Dan Buchanan
Identifying and investigating clinically and biologically relevant subtypes of colorectal cancer (CRC).
Genomics Platform Group | A/Prof Oliver Hofmann
Improving the scalability and reliability of sequencing workflows, better detection of changes in cancer genomes, and aiming to make tumour data accessible in real time.
Molecular Biomarkers and Translational Genomics Lab | Professor Sarah-Jane Dawson
Developing improved molecular biomarkers for early detection, risk stratification and disease monitoring in cancer.
Palliative Care Nexus | Professor Jennifer Philip
Seeking to effect positive and systemic change in palliative care practice, and accelerate the translation of research-generated knowledge to improve patient care.
Precision Oncology | Professor Sean Grimmond
Exploring mutational signatures of DNA and their contributions to individual tumours, through rapid genomic analysis.
Precision Prevention and Early Detection of Colorectal Cancer | Professor Mark Jenkins
Undertaking a comprehensive approach to reduce the burden of colorectal cancer and improve results for patients.
Prostate Cancer Research Group | Prof Chris Hovens & A/Prof Niall Corcoran
Determining prostate cancer aggressiveness, metastatic potential and the molecular drivers of treatment resistance.
Rare Disease Oncogenomics | Dr Richard Tothill
Dedicated to translational research of rare and less common cancers.
Tumour Heterogeneity in Metastatic Cancer | Prof Frédéric Hollande
Understanding the mechanisms that underlie the genetic and non-genetic heterogeneity within individual tumours, and characterising the role it plays on metastatic progression and treatment response.